BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: N Augustine T. The aegis: platelets as biomarkers of tumor progression. Biomark Med 2020;14:573-85. [PMID: 32462904 DOI: 10.2217/bmm-2019-0514] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Guo J, Ye Y, Liu Y, Wu W, Mei Q, Zhang X, Lao J, Wang B, Wang J. Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma. Front Med 2022;9. [DOI: 10.3389/fmed.2022.947729] [Reference Citation Analysis]
2 Filippelli A, Del Gaudio C, Simonis V, Ciccone V, Spini A, Donnini S. Scoping Review on Platelets and Tumor Angiogenesis: Do We Need More Evidence or Better Analysis? IJMS 2022;23:13401. [DOI: 10.3390/ijms232113401] [Reference Citation Analysis]
3 李 晨. Correlation between 4 Inflammatory Indicators and Prognosis of Patients with Stage III Breast Cancer. ACM 2022;12:10168-10174. [DOI: 10.12677/acm.2022.12111466] [Reference Citation Analysis]
4 Ekmekci S, Aktas S. The Concept and Mechanisms of Metastasis. Biomarkers in Carcinoma of Unknown Primary 2022. [DOI: 10.1007/978-3-030-84432-5_2] [Reference Citation Analysis]
5 Li W, Ma G, Deng Y, Chen W, Liu Z, Chen F, Wu Q. Systemic Immune-Inflammation Index Is a Prognostic Factor for Breast Cancer Patients After Curative Resection. Front Oncol 2021;11:570208. [PMID: 34926234 DOI: 10.3389/fonc.2021.570208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Xulu KR, Augustine TN. Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation. Int J Mol Sci 2021;22:4153. [PMID: 33923802 DOI: 10.3390/ijms22084153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]